Brind.
  1. Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.

Pfizer acquired Seagen for its cancer drug candidates, while a separate deal with Innovent helps offset revenue decline.

2 reports, 2 independent Updated Sep 1
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Pfizer acquired Seagen for its cancer drug candidates, while a separate deal with Innovent helps offset revenue decline.

Who's involved

What this event is mainly about
PfizerInnovent BiologicsSeagen

How it developed

Newest first. Tap a step to see who reported it.
  1. Innovent Biologics and Pfizer announced a major partnership worth up to $10.5 billion.1 source
  2. Pfizer acquired Seagen for its cancer drug candidates.1 source

Keep exploring

Part of

Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.

Also in this story

All 4 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped